Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Multiple Endocrine Neoplasia Type 1 4Neoplasms 2Skin Neoplasms 1Rosacea 1Psoriasis 1Pregnancy Complications 1Neurologic Manifestations 1Metabolic Diseases 1Melanoma 1Endocrine System Diseases 1Diabetes Mellitus 1Dermatitis, Atopic 1Cerebrovascular Disorders 1Cardiovascular Diseases 1

Interventions

Etanercept 7tofacitinib 6Adalimumab 4Methotrexate 3secukinumab 2sotrastaurin 1sodium luminolate 1purine 1ixekizumab 1fumaric acid 1calcipotriene 1baricitinib 1apremilast 1Vitamin D 1Vaccines 1Sulfasalazine 1Saline Solution 1Mesalamine 1Mercaptopurine 1Infliximab 1Herpes Zoster Vaccine 1Folic Acid 1Fish Oils 1Fatty Acids, Omega-3 1Eicosapentaenoic Acid 1Eating 1Docosahexaenoic Acids 1Cholecalciferol 1Biopsy 1Anti-Infective Agents, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Psoriasis × Eating × Clear all
NCT03253666 2020-07-15

Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)

Harvard School of Public Health (HSPH)

Completed
173,229 enrolled
Dermatologic

Dermatitis, Atopic, Melanoma, Psoriasis, Rosacea, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡